Will allogeneic CAR T cells for CD19+ malignancies take autologous CAR T cells 'off the shelf'?

被引：31

作者：

DiNofia, Amanda M. ^{[1
,2
]}

Grupp, Stephan A. ^{[1
,2
]}

机构：

[1] Childrens Hosp Philadelphia, Cellular Therapy & Transplant Sect, Canc Immunotherapy Program, Philadelphia, PA 19104 USA

[2] Univ Penn, Dept Pediat, Div Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA

来源：

NATURE REVIEWS CLINICAL ONCOLOGY | 2021年 / 18卷 / 04期

关键词：

D O I：

10.1038/s41571-021-00485-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The question of whether allogeneic chimeric antigen receptor (CAR) T cells could replace autologous CAR T cell therapy has garnered considerable interest, but limited data have been available for comparisons to date. Now, Benjamin et al. have reported their experience with allogeneic anti-CD19 CAR T cells in 21 paediatric and adult patients with acute lymphoblastic leukaemia.

引用

页码：195 / 196

页数：2

共 50 条

[31] Human CD19-specific switchable CAR T-cells are efficacious as constitutively active CAR T-cells but cause less morbidity in a mouse model of human CD19+ malignancy
Pennell, Christopher A.
Campbell, Heather
Storlie, Meghan D.
Bolivar-Wagers, Sara
Osborn, Mark J.
Refaeli, Yosef
Jensen, Michael
Viaud, Sophie
Young, Travis S.
Blazar, Bruce R.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (12)
[32] CAR T cells take centre stage
Beavis, Paul A.
Darcy, Phillip K.
CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2019, 8 (07)
[33] Targeting CD47 in lymphoid malignancies with CAR T cells
Boardman, Alexander Paul
James, Scott
Van den Brink, Marcel R. M.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[34] Allogeneic CD7-CAR T cells to bridge the gap?
Velasquez, M. Paulina
TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (03): : 139 - 140
[35] Allogeneic CAR T cells show promise
Sidaway, Peter
NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (12) : 748 - 748
[36] Allogeneic CAR T-Cells (UCART)
Galetto, Roman
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2018, 202 (07): : 1421 - 1430
[37] Development of allogeneic CAR T-cells
Alcazer, Vincent
Depil, Stephane
BULLETIN DU CANCER, 2021, 108 (10) : S73 - S80
[38] Allogeneic CAR T cells show promise
Peter Sidaway
Nature Reviews Clinical Oncology, 2022, 19 : 748 - 748
[39] EVALUATION OF NON-GENE EDITED ALLOGENEIC "OFF-THE-SHELF" Vδ1 γδ CAR T CELLS TARGETING CD20 FOR B CELL MALIGNANCIES
Azameera, A.
Lamture, G.
Au, M.
Barca, T.
Teague, A.
Wong, J.
Gundurao, S. R.
Doan, A.
Herrman, M.
Panuganti, S.
Bhat, A.
Aftab, B. T.
Nishimoto, K.
CYTOTHERAPY, 2022, 24 (05) : S111 - S111
[40] CAR T cells: Building on the CD19 paradigm
Globerson-Levin, Anat
Riviere, Isabelle
Eshhar, Zelig
Sadelain, Michel
EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 (09) : 2151 - 2163

← 1 2 3 4 5 →